Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Spring Bank Ph CS (SBPH)

Spring Bank Ph CS (SBPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,893
  • Shares Outstanding, K 17,267
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,100 K
  • 60-Month Beta 1.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.14
Trade SBPH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/26/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +40.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9710 +24.61%
on 10/30/20
1.5400 -21.43%
on 11/12/20
-0.0400 (-3.20%)
since 10/20/20
3-Month
0.9710 +24.61%
on 10/30/20
1.5500 -21.94%
on 09/03/20
-0.2100 (-14.79%)
since 08/20/20
52-Week
0.8000 +51.25%
on 03/16/20
4.8000 -74.79%
on 12/02/19
-1.9900 (-62.19%)
since 11/20/19

Most Recent Stories

More News
Galecto Appoints Garrett Winslow as General Counsel

Galecto, Inc. (NASDAQ: GLTO), a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that Garrett Winslow has joined the Company as...

SBPH : 4.8400 (unch)
GLTO : 3.85 (unch)
OncoNano Medicine Announces Martin Driscoll as Chief Executive Officer

OncoNano Medicine, Inc. today announced the appointment of Martin Driscoll as Chief Executive Officer and a member of the company's Board of Directors. An accomplished industry veteran with multiple decades...

SBPH : 4.8400 (unch)
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals

CAMBRIDGE, England and , /PRNewswire/ -- F-star Therapeutics, Inc., (Nasdaq: FSTX, as of ) a clinical-stage immuno-oncology company determined to transform the lives of patients with cancer through...

SBPH : 4.8400 (unch)
CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

, /PRNewswire/ -- Please replace the release dated November 19, 2020 with the following corrected version due to revisions to the headline.

SBPH : 4.8400 (unch)
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) ("Spring Bank"), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, announced that at its...

SBPH : 4.8400 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm - MVC, WPX, PTI, SBPH

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

MVC : 9.12 (+2.59%)
WPX : 9.43 (+5.36%)
PTI : 1.1100 (-3.48%)
SBPH : 4.8400 (unch)
SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, WPX, VRTU, and SBPH Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

IPHI : 172.27 (-1.08%)
MRVL : 63.61 (+0.27%)
WPX : 9.43 (+5.36%)
VRTU : 51.33 (+0.03%)
SBPH : 4.8400 (unch)
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights

Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) ("Spring Bank"), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced that its...

SBPH : 4.8400 (unch)
Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced an upcoming trial-in-progress...

SBPH : 4.8400 (unch)
ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - MR, MYOK, CBLI, SBPH, PTI, PRCP

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

MR : 5.36 (-1.29%)
MYOK : 224.91 (+0.05%)
CBLI : 3.17 (-7.31%)
SBPH : 4.8400 (unch)
PTI : 1.1100 (-3.48%)
PRCP : 6.98 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.3764
1st Resistance Point 1.2932
Last Price 4.8400
1st Support Level 1.1384
2nd Support Level 1.0668
3rd Support Level N/A

See More

Last Price 4.8400
52-Week High 4.8000
Fibonacci 61.8% 3.2720
Fibonacci 50% 2.8000
Fibonacci 38.2% 2.3280
52-Week Low 0.8000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar